Are we turning "clinically proven" into just another marketing buzzword?

In this Sticky Notes live episode, Denali and Brad dive into how the public encounters *clinical trials* not through journals or regulators, but through mushroom coffee emails, peptide ads, and GLP‑1 hype on social media. From biohacking with gray‑market peptides to the underrepresentation of women in research, this conversation pulls back the curtain on how science, perception, and marketing collide.

🧪 **In this episode we cover:** - **National Doctor–Patient Trust Day & St. Patrick's Day:** Lighthearted banter about trust in medicine, drunk crowds, and corned beef vs. Taco Tuesday. - **Mushroom Coffee & "Clinically Proven" Marketing:** An 8‑week "randomized clinical study" in a marketing email: what does that really mean? Who's running these trials, where's the FDA, and how much should we trust claims like "clinically tested"? - **Vitamin B12, GLP‑1s, and Safety Trade‑offs:** Emerging concerns about impurities and interactions in GLP‑1 compounding. How fast is *too* fast when it comes to development, approval, and post‑market surprises? - **Peptides, Biohacking & the Gray Market:** Ordering research‑grade peptides and GLP‑1 analogs straight from overseas. N=1 "self‑experiments," influencer before/after pics, and where personal autonomy meets real safety risk. - **Why Women Are Underrepresented in Trials:** A study showing women are 51% of the population but only ~41% of trial participants. Logistics, fear, eligibility criteria, and how trial design and history stack the deck. Would men give the same reasons for *not* joining a trial?

🎧 **Who this episode is for:** - Clinical research professionals who want an honest, unfiltered take on how the public actually sees trials - Sponsors, sites, and CROs thinking about trust, recruitment, and representation - Anyone tempted by "clinically proven" supplements, peptides, or weight‑loss injections - Curious listeners who like candid, sometimes irreverent conversations about medicine and research

---

🔔 **Subscribe** to Note to File for more independent, unfiltered conversations about the clinical trial industry. 💬 Have a topic you'd like us to tackle next? Drop it in the comments or reach out at **notetofilepodcast.com**.